Foresite Capital Management III’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $18.7M | Hold |
|
|||||
|
2021
Q2 | $13.6M | Hold |
|
|||||
|
2021
Q1 | $14.7M | Hold |
|
|||||
|
2020
Q4 | $13.9M | Hold |
|
|||||
|
2020
Q3 | $12.2M | Buy |
|
|||||
|
2020
Q2 | $4M | Hold |
|
|||||
|
2020
Q1 | $3.78M | Sell |
|
|||||
|
2019
Q4 | $13.5M | Hold |
|
|||||
|
2019
Q3 | $10.1M | Hold |
|
|||||
|
2019
Q2 | $10.5M | Hold |
|
|||||
|
2019
Q1 | $11.9M | Buy |
|
|||||
|
2018
Q4 | $10.3M | Sell |
|
|||||
|
2018
Q3 | $14.4M | Sell |
|
|||||
|
2018
Q2 | $13.5M | Hold |
|
|||||
|
2018
Q1 | $10.9M | Hold |
|
|||||
|
2017
Q4 | $11.8M | Hold |
|
|||||
|
2017
Q3 | $10.4M | Buy |
|
|||||
|
2017
Q2 | $604K | Hold |
|
|||||
|
2017
Q1 | $526K | Hold |
|
|||||
|
2016
Q4 | $507K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $2.49M | Buy |
|
|||||
|
2015
Q4 | $2.44M | Buy |
|